← Open Payments lookup

RACHEL BROWN: Open Payments

NPI 1750940375 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$736 in 11 payments from 9 companies in 2025. Trend: 2023 $641 · 2024 $574 · 2025 $736

Food & beverage: $736
CompanyPaymentsAmount
Alexion Pharmaceuticals, Inc.2$194
Alnylam Pharmaceuticals Inc.1$120
TG Therapeutics, Inc.1$107
ARGENX US, INC.1$104
Janssen Biotech, Inc.1$81
Genentech USA, Inc.2$55
Amgen Inc.1$30
Eisai Inc.1$24
GENZYME CORPORATION1$22

Products named: ULTOMIRIS, AMVUTTRA, BRIUMVI, VYVGART, TREMFYA, Ocrevus Zunovo, Xolair, Leqembi.

Industry payments across MI — which companies pay providers there.